NIH-funded research U01 cooperative agreement

Restoring the ability to notice low blood sugar in people with type 1 diabetes

Official title: University of Minnesota Clinical Center for the Restoration of Impaired Awareness of Hypoglycemia in Type 1 Diabetes

Funded at University of Minnesota · NIH-11319759 · Data updated 2026-11-12

This project helps people with type 1 diabetes who can’t feel low blood sugar avoid lows and try a hybrid closed‑loop insulin system to see if their ability to notice hypoglycemia comes back.

More Diabetes research and trials

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionUniversity of Minnesota
NIH-funded
Lab location1 site (Minneapolis, United States)
Project startSeptember 25, 2022
Project endDecember 31, 2027
Funding year2026
Award (this year)$826,620
NIH project number5U01DK135130-04
Project IDNIH-11319759 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are people with type 1 diabetes who have impaired awareness of hypoglycemia or a history of recurrent severe lows and who can use continuous glucose monitoring and insulin delivery devices.

Less likely to help

People without impaired hypoglycemia awareness, those with type 2 diabetes, or those unable/unwilling to use pump/CGM technology are unlikely to benefit from this trial.

What this research studies

You would be invited to join a randomized trial enrolling about 650 people with type 1 diabetes who have impaired awareness of hypoglycemia. For 12 months, some participants will receive focused hypoglycemia‑avoidance education plus a hybrid closed‑loop insulin delivery system while others receive current standard care. The research team will track blood glucose, hormone responses, metabolic tests, and questionnaires to find out which factors (for example age, diabetes duration, and glucose patterns) are linked to regaining awareness. The University of Minnesota center is part of a consortium coordinating the protocol and standardized testing across participating sites.

Why it matters

Potential benefit: If successful, the approach could help people with impaired awareness of hypoglycemia regain warning symptoms, lower the risk of severe lows, and improve safe glucose control.

How similar studies have gone: Previous work shows hypoglycemia avoidance and hybrid closed‑loop systems reduce low blood‑sugar events, but restoring awareness varies between people, so this trial builds on prior successes to find who benefits.

Where this research is happening

  • University of Minnesota
    Minneapolis, United States
    Active

Researchers

  • Principal investigator: Seaquist, Elizabeth R. — University of Minnesota
  • Study coordinator: Seaquist, Elizabeth R.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.